ADVERTISEMENT

Volume 22, Issue 2

Pages 151-296, e41-e65 (February 2022)

Actions for selected articles

/

Receive an update when the latest issues in this journal are published
Sign in to set up alerts
  1. Time for Africa to future-proof, starting with COVID-19

    Page 151
    Download PDF
  2. What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?

    Pages 152-153
    Download PDF
  3. Remdesivir, on the road to DisCoVeRy

    Pages 153-155
    Download PDF
  4. Sex-disaggregated tuberculosis data call for gender-equitable tuberculosis control

    Pages 155-156
    Purchase PDF
  5. Xpert MTB/XDR for rapid detection of drug-resistant tuberculosis beyond rifampicin

    Pages 156-157
    Purchase PDF
  6. Timing is everything when it comes to pertussis vaccination

    Pages 158-159
    Purchase PDF
  7. Community-acquired pneumonia: is less more?

    Pages 159-161
    Purchase PDF
  8. Polio eradication: what kind of world do we want?

    Pages 161-163
    Download PDF
  9. Discordant results of tests for tuberculosis reconsidered

    Page 164
    Purchase PDF
  10. Discordant results of tests for tuberculosis reconsidered – Authors' reply

    Pages 164-165
    Purchase PDF
  11. Has the COVID-19 pandemic increased tuberculosis mortality?

    Pages 165-166
    Download PDF
  12. Implications of bedaquiline-resistant tuberculosis

    Page 166
    Purchase PDF
  13. Implications of bedaquiline-resistant tuberculosis

    Pages 166-167
    Purchase PDF
  14. Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in China, 2016–20

    Pages 167-168
    Purchase PDF
  15. Polio amid a humanitarian crisis in Afghanistan: challenges and recommendations

    Pages 168-169
    Download PDF
  16. Correction to Lancet Infect Dis 2022; 22: 31

    Page e41
    Download PDF
  17. Correction to Lancet Infect Dis 2022; 22: 250–64

    Page e41
    Download PDF
  18. Correction to Lancet Infect Dis 2022; 22: 284–94

    Page e41
    Download PDF
  19. A new strategy is required for malaria elimination in Africa

    Pages 170-171
    Purchase PDF
  20. Inequalities hinder infectious disease control

    Page 172
    Purchase PDF
  21. Antimicrobial use and resistance in England, 2020–21

    Page 173
    Purchase PDF
  22. The origin of SARS-CoV-2 variants of concern

    Pages 174-175
    Download PDF
  23. Infectious disease surveillance update

    Page 175
    Purchase PDF
  24. Research in brief

    Page 176
    Download PDF
  25. Malcolm Molyneux

    Page 177
    Download PDF
  26. Alexandra King—promoting Indigenous self-determination

    Page 178
    Purchase PDF
  27. Laura Hammitt—prioritising Native American health

    Page 179
    Purchase PDF
  28. Ordinary people in extraordinary times

    Page 180
    Purchase PDF
  29. Survival sex: “I have no option left”

    Page 181
    Purchase PDF
  30. Illuminating the shadows in a Brazilian AIDS community

    Page 182
    Purchase PDF
  31. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

    Pages 183-195
    Download PDF
  32. Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

    Pages 196-208
    Download PDF
  33. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

    Pages 209-221
    Download PDF
  34. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019

    Pages 222-241
    Download PDF
  35. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study

    Pages 242-249
    Purchase PDF
  36. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis

    Pages 250-264
    Purchase PDF
  37. Effect of change in vaccine schedule on pertussis epidemiology in France: a modelling and serological study

    Pages 265-273
    Purchase PDF
  38. Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial

    Pages 274-283
    Purchase PDF
  39. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa

    Pages 284-294
    Download PDF
  40. Knowledge gaps in the epidemiology of severe dengue impede vaccine evaluation

    Pages e42-e51
    Purchase PDF
  41. Prevention of host-to-host transmission by SARS-CoV-2 vaccines

    Pages e52-e58
    Download PDF
  42. Acanthamoeba castellanii encephalitis in a patient with AIDS: a case report and literature review

    Pages e59-e65
    Purchase PDF
  43. Atypical imported loiasis characterised by recurrent anaemia in a patient from China

    Page 295
    Purchase PDF
  44. A brain problem with Listeria monocytogenes

    Page 296
    Purchase PDF

ISSN: 1473-3099